Radiation, Chemotherapy with Surgery for Localized Chest Wall Sarcoma Beneficial

Share this content:

the Cancer Therapy Advisor take:

According to a new study published in the American Journal of Clinical Oncology, researchers at University of Washington Medical Center in Seattle, Washington, have found that the addition of radiotherapy, chemotherapy, or both to surgery improves outcomes for patients with localized chest wall sarcoma.

For the single-institution study, researchers sought to investigate the 20-year experience of the impact on outcome of radiotherapy and chemotherapy in the treatment of localized chest wall sarcomas at a single institution.

They retrospectively analyzed data from 65 patients with stage 2B and 3 chest wall sarcomas. Results showed that compared with surgery alone, disease-free survival improved by 92% with the addition of radiotherapy and by 82% with the addition of chemotherapy at both 5 and 10 years.

Furthermore, the addition of both radiotherapy and chemotherapy to surgery improved disease-free survival by 89% and 90% at 5 and 10 years, respectively. 

Researchers also found that the addition of either radiotherapy or chemotherapy, or both, improved overall survival, but the greatest improvement was observed in patients that received chemotherapy and radiotherapy with surgery.

The findings suggest that the addition of radiotherapy, chemotherapy, or both to surgery should be strongly considered in patients with localized chest wall sarcoma, but larger studies are necessary to determine which populations would benefit most from both radiotherapy and chemotherapy.

Extending duration of dual anti-HER2 therapy without chemotherapy did not significantly improve mole
Addition of radiotherapy, chemotherapy, or both to surgery improves outcomes for patients with localized chest wall sarcoma.
Objective of this study is to evaluate the impact on the outcome of radiation therapy and chemotherapy in the treatment of localized chest wall sarcomas. The addition of radiation therapy, chemotherapy, or both to surgery in localized chest wall sarcoma improves outcome and should strongly be considered for patients with acceptable comorbidities.
READ FULL ARTICLE From Mdlinx

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs